London, UK, and Cambridge, MA: 29 July 2010 Antisoma plc (LSE: ASM; USOTC:ATSMY) today announces its preliminary results for the year ended 30 June 2010.These results have been prepared under International Financial ReportingStandards (’IFRS’) as adopted for use by the European Union.Key events of 2009/2010AS1413 * Positive final data reported from secondary AML phase [...]
London, July 22 (ANI): Medics in Great Britain have come up with an innovative new knee replacement system that lets patients take steps just two hours post-op.The system was developed by consultant orthopedic surgeon Tony Smith at North Wales NHS Trust, who worked with physiotherapists, anesthetists, hospital managers and nurses.New aesthetic techniques, along with very [...]
Research findings, ‘Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial,’ are discussed in a new report. According to a study from London, the United Kingdom, "Tranexamic acid can reduce bleeding in patients undergoing elective surgery. We assessed the effects of [...]
New investigation results, ‘Screening for cardiovascular disease in patients with advanced chronic kidney disease,’ are detailed in a study published in Journal of Renal Care. "Cardiovascular disease remains the major cause of mortality and morbidity in patients with advanced chronic kidney disease (CKD) and after renal transplantation. The mechanisms for cardiotoxicity are multiple," scientists in [...]
Investigators publish new data in the report ‘Risk of revision of a total hip replacement in patients with diabetes mellitus: a population-based follow up study.’ "We have evaluated the extent to which diabetes affects the revision rate following total hip replacement (THR). Through the Danish Hip Arthroplasty Registry we identified all patients undergoing a primary [...]
According to recent research from London, the United Kingdom, "The purpose of this study was to assess macular perfusion with fundus fluorescein angiography at the 4-month time point in a prospective randomized, single-center 2-year trial comparing intravitreal bevacizumab and laser therapy in patients with diabetic macular edema. All enrolled patients had standard Early Treatment of [...]
Researchers detail in ‘Does a social model of hospice day care affect advanced cancer patients’ use of other health and social services? A prospective quasi-experimental trial,’ new data in patient care. "Hospice day care (HDC) services have developed but no trials evaluate their impact on the other health and social care services. The purpose of [...]
A new study, ‘Hybrid treatment of complex aortic arch disease with supra-aortic debranching and endovascular stent graft repair,’ is now available. "Aortic arch disease has conventionally been the domain of open surgical repair. Hybrid open and endovascular repair has evolved as an alternative, less invasive, treatment option with promising results," scientists in London, the United [...]
Merck KGaA / Regulatory Admission28.07.2010 08:00Dissemination of an Ad hoc announcement according to 15 WpHG, transmitted byDGAP – a company of EquityStory AG.The issuer is solely responsible for the content of this announcement.-Darmstadt, Germany, July 28, 2010 – Merck KGaA announced today that theU.S. Food and Drug Administration (FDA) has accepted for filing the [...]
Scientists discuss in ‘Two countries divided by a common language: health systems in the UK and USA’ new findings in cancer research. "Despite the historic significance of the healthcare reform bill that was passed into law by President Obama in March 2010, the debate still rages. The UK National Health Service (NHS) has featured prominently [...]
